James Investment Research’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-200
| Closed | -$11K | – | 493 |
|
|
2023
Q1 | $11K | Hold |
200
| – | – | ﹤0.01% | 477 |
|
|
2022
Q4 | $10K | Hold |
200
| – | – | ﹤0.01% | 479 |
|
|
2022
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 469 |
|
|
2022
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 448 |
|
|
2022
Q1 | $10K | Hold |
200
| – | – | ﹤0.01% | 449 |
|
|
2021
Q4 | $10K | Hold |
200
| – | – | ﹤0.01% | 456 |
|
|
2021
Q3 | $10K | Hold |
200
| – | – | ﹤0.01% | 444 |
|
|
2021
Q2 | $11K | Hold |
200
| – | – | ﹤0.01% | 449 |
|
|
2021
Q1 | $10K | Hold |
200
| – | – | ﹤0.01% | 436 |
|
|
2020
Q4 | $10K | Hold |
200
| – | – | ﹤0.01% | 463 |
|
|
2020
Q3 | $10K | Hold |
200
| – | – | ﹤0.01% | 424 |
|
|
2020
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 398 |
|
|
2020
Q1 | $9K | Sell |
200
-344
| -63% | -$16.5K | ﹤0.01% | 387 |
|
|
2019
Q4 | $27K | Hold |
544
| – | – | ﹤0.01% | 424 |
|
|
2019
Q3 | $25K | Hold |
544
| – | – | ﹤0.01% | 468 |
|
|
2019
Q2 | $24K | Hold |
544
| – | – | ﹤0.01% | 553 |
|
|
2019
Q1 | $24K | Hold |
544
| – | – | ﹤0.01% | 689 |
|
|
2018
Q4 | $24K | Hold |
544
| – | – | ﹤0.01% | 697 |
|
|
2018
Q3 | $24K | Hold |
544
| – | – | ﹤0.01% | 733 |
|
|
2018
Q2 | $22K | Hold |
544
| – | – | ﹤0.01% | 732 |
|
|
2018
Q1 | $22K | Hold |
544
| – | – | ﹤0.01% | 726 |
|
|
2017
Q4 | $23K | Hold |
544
| – | – | ﹤0.01% | 710 |
|
|
2017
Q3 | $27K | Hold |
544
| – | – | ﹤0.01% | 674 |
|
|
2017
Q2 | $26K | Hold |
544
| – | – | ﹤0.01% | 651 |
|
|
2017
Q1 | $25K | Hold |
544
| – | – | ﹤0.01% | 586 |
|
|
2016
Q4 | $22K | Hold |
544
| – | – | ﹤0.01% | 467 |
|
|
2016
Q3 | $21K | Hold |
544
| – | – | ﹤0.01% | 460 |
|
|
2016
Q2 | $23K | Buy |
544
+106
| +24% | +$4.35K | ﹤0.01% | 409 |
|
|
2016
Q1 | $18K | Hold |
438
| – | – | ﹤0.01% | 402 |
|
|
2015
Q4 | $19K | Hold |
438
| – | – | ﹤0.01% | 424 |
|
|
2015
Q3 | $21K | Buy |
438
+200
| +84% | +$10.2K | ﹤0.01% | 399 |
|
|
2015
Q2 | $12K | Hold |
238
| – | – | ﹤0.01% | 478 |
|
|
2015
Q1 | $12K | Hold |
238
| – | – | ﹤0.01% | 487 |
|
|
2014
Q4 | $11K | Hold |
238
| – | – | ﹤0.01% | 488 |
|
|
2014
Q3 | $13K | Hold |
238
| – | – | ﹤0.01% | 478 |
|
|
2014
Q2 | $13K | Hold |
238
| – | – | ﹤0.01% | 472 |
|
|
2014
Q1 | $12K | Hold |
238
| – | – | ﹤0.01% | 480 |
|
|
2013
Q4 | $13K | Hold |
238
| – | – | ﹤0.01% | 469 |
|
|
2013
Q3 | $12K | Hold |
238
| – | – | ﹤0.01% | 473 |
|
|
2013
Q2 | $12K | Buy |
+238
| New | +$12.7K | ﹤0.01% | 462 |
|
Other funds holding SNY
CCM
James Investment Research's SNY Position: Q2 2023 in Review
James Investment Research sold out of Sanofi (SNY) in Q2 2023, closing a stake of 200 shares — an estimated $11K sold.
James Investment Research first reported a position in SNY in Q2 2013 and held it in 40 quarters. The position peaked at $27K in Q4 2019. 672 funds tracked by Wall St. Rank hold SNY as of Q2 2023.
- James Investment Research reported no remaining Sanofi position as of Q2 2023 after selling out during the quarter.
- James Investment Research sold 200 Sanofi shares in Q2 2023, an estimated $11K.
- James Investment Research first reported a position in Sanofi in Q2 2013 and held it in 40 quarters.
- James Investment Research's Sanofi position peaked at $27K in Q4 2019.
- 672 funds tracked by Wall St. Rank held Sanofi as of Q2 2023.
Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.